{ "access": { "embargo": { "active": false, "reason": null }, "files": "public", "record": "public", "status": "open" }, "created": "2021-03-22T15:23:22.922003+00:00", "custom_fields": {}, "deletion_status": { "is_deleted": false, "status": "P" }, "files": { "count": 1, "enabled": true, "entries": { "Plectin_PLEC-YCharOS report.pdf": { "checksum": "md5:0566c717480ee7af24821de9fc657e00", "ext": "pdf", "id": "a28a9645-b8be-4b8e-a719-bb5fe50f0327", "key": "Plectin_PLEC-YCharOS report.pdf", "metadata": null, "mimetype": "application/pdf", "size": 1585368 } }, "order": [], "total_bytes": 1585368 }, "id": "4627530", "is_draft": false, "is_published": true, "links": { "access": "https://zenodo.org/api/records/4627530/access", "access_links": "https://zenodo.org/api/records/4627530/access/links", "access_request": "https://zenodo.org/api/records/4627530/access/request", "access_users": "https://zenodo.org/api/records/4627530/access/users", "archive": "https://zenodo.org/api/records/4627530/files-archive", "archive_media": "https://zenodo.org/api/records/4627530/media-files-archive", "communities": "https://zenodo.org/api/records/4627530/communities", "communities-suggestions": "https://zenodo.org/api/records/4627530/communities-suggestions", "doi": "https://doi.org/10.5281/zenodo.4627530", "draft": "https://zenodo.org/api/records/4627530/draft", "files": "https://zenodo.org/api/records/4627530/files", "latest": "https://zenodo.org/api/records/4627530/versions/latest", "latest_html": "https://zenodo.org/records/4627530/latest", "media_files": "https://zenodo.org/api/records/4627530/media-files", "parent": "https://zenodo.org/api/records/4627529", "parent_doi": "https://zenodo.org/doi/10.5281/zenodo.4627529", "parent_html": "https://zenodo.org/records/4627529", "requests": "https://zenodo.org/api/records/4627530/requests", "reserve_doi": "https://zenodo.org/api/records/4627530/draft/pids/doi", "self": "https://zenodo.org/api/records/4627530", "self_doi": "https://zenodo.org/doi/10.5281/zenodo.4627530", "self_html": "https://zenodo.org/records/4627530", "self_iiif_manifest": "https://zenodo.org/api/iiif/record:4627530/manifest", "self_iiif_sequence": "https://zenodo.org/api/iiif/record:4627530/sequence/default", "versions": "https://zenodo.org/api/records/4627530/versions" }, "media_files": { "count": 0, "enabled": false, "entries": {}, "order": [], "total_bytes": 0 }, "metadata": { "creators": [ { "affiliations": [ { "name": "Montreal Neurological Institute" } ], "person_or_org": { "family_name": "Ayoubi", "given_name": "Riham", "identifiers": [ { "identifier": "0000-0001-6633-655X", "scheme": "orcid" } ], "name": "Ayoubi, Riham", "type": "personal" } }, { "affiliations": [ { "name": "Montreal Neurological Institute" } ], "person_or_org": { "family_name": "Fotouhi", "given_name": "Maryam", "identifiers": [ { "identifier": "0000-0001-8937-4719", "scheme": "orcid" } ], "name": "Fotouhi, Maryam", "type": "personal" } }, { "affiliations": [ { "name": "Montreal Neurological Institute" } ], "person_or_org": { "family_name": "McPherson", "given_name": "Peter", "identifiers": [ { "identifier": "0000-0001-7806-5662", "scheme": "orcid" } ], "name": "McPherson, Peter", "type": "personal" } }, { "affiliations": [ { "name": "Montreal Neurological Institute" } ], "person_or_org": { "family_name": "Laflamme", "given_name": "Carl", "identifiers": [ { "identifier": "0000-0001-5906-025X", "scheme": "orcid" } ], "name": "Laflamme, Carl", "type": "personal" } } ], "description": "
Head to head comparison of available commercial antibodies against Plectin by immunoblot (Western blot), immunoprecipitation and immunofluorescence.
", "funding": [ { "award": { "id": "01cwqze88::3RF1AG057443-01S2", "number": "3RF1AG057443-01S2", "program": "NATIONAL_INSTITUTE_ON_AGING", "title": { "en": "Infrastructure to improve reliability of AMP-AD target hypotheses" } }, "funder": { "id": "01cwqze88", "name": "National Institutes of Health" } } ], "languages": [ { "id": "eng", "title": { "en": "English" } } ], "publication_date": "2021-03-22", "publisher": "Zenodo", "resource_type": { "id": "publication-article", "title": { "de": "Zeitschriftenartikel", "en": "Journal article" } }, "rights": [ { "description": { "en": "The Creative Commons Attribution license allows re-distribution and re-use of a licensed work on the condition that the creator is appropriately credited." }, "icon": "cc-by-icon", "id": "cc-by-4.0", "props": { "scheme": "spdx", "url": "https://creativecommons.org/licenses/by/4.0/legalcode" }, "title": { "en": "Creative Commons Attribution 4.0 International" } } ], "subjects": [ { "subject": "Plectin" }, { "subject": "Hemidesmosomal protein 1" }, { "subject": "HD1" }, { "subject": "Plectin-1" }, { "subject": "PLEC" }, { "subject": "Q15149" }, { "subject": "antibody characterization" }, { "subject": "antibody validation" } ], "title": "Antibody Characterization Report for Plectin", "version": "1.0.0" }, "parent": { "access": { "owned_by": { "user": 203156 } }, "communities": { "entries": [ { "access": { "member_policy": "open", "members_visibility": "public", "record_policy": "open", "review_policy": "open", "visibility": "public" }, "children": { "allow": false }, "created": "2021-11-09T00:02:01.737379+00:00", "custom_fields": {}, "deletion_status": { "is_deleted": false, "status": "P" }, "id": "202e8f59-215b-490f-a257-f0273d2ec041", "links": {}, "metadata": { "curation_policy": "This community accepts work generated by the TREAT-AD consortium and collaborators.
\r\n", "page": "The overarching purpose of the TREAT-AD program is to improve, diversify and reinvigorate the Alzheimer’s disease (AD) drug development pipeline by accelerating the characterization and experimental validation of next generation therapeutic targets and integrating the targets into drug discovery campaigns. In addition, this program aims to de-risk potential therapeutics to the point that industry will invest in them, accelerating the delivery of new drugs to AD patients. To this end, the funded Centers (Emory-Sage-SGC and IUSM-Purdue) will 1) design, develop and disseminate tools that support target enabling packages (TEPs) for the experimental validation of novel, next generation therapeutic targets, including those emanating from the NIA-funded, target discovery programs such as Accelerating Medicines Partnership-Alzheimer’s Disease (AMP-AD), and 2) initiate early stage drug discovery campaigns against the enabled targets. Central to this initiative is the open-access, rapid dissemination of data, methods, and computational and experimental tools generated by the Centers to all qualified researchers for their use in advancing AD drug discovery and AD disease biology.
\r\n\r\nFor more information, please visit our website: https://treatad.org/.
\r\n\r\nFor a catalog of resources, please visit the AD Knowledge Portal Target Enabling Resources
\r\n\r\n", "title": "TREAT-AD: TaRget Enablement to Accelerate Therapy Development for AD" }, "revision_id": 0, "slug": "treatad", "updated": "2021-11-10T22:20:26.509186+00:00" }, { "access": { "member_policy": "open", "members_visibility": "public", "record_policy": "open", "review_policy": "open", "visibility": "public" }, "children": { "allow": false }, "created": "2017-12-07T17:07:01.244312+00:00", "custom_fields": {}, "deletion_status": { "is_deleted": false, "status": "P" }, "id": "23286851-d31a-4dfe-9957-6de5a081d5bb", "links": {}, "metadata": { "curation_policy": "
SGC Open Notebooks
\r\n", "description": "SGC Open Notebooks", "page": "SGC Open Notebooks
\r\n", "title": "SGC Open Notebooks" }, "revision_id": 0, "slug": "sgc-opennotebook", "updated": "2017-12-07T17:07:01.244323+00:00" }, { "access": { "member_policy": "open", "members_visibility": "public", "record_policy": "open", "review_policy": "open", "visibility": "public" }, "children": { "allow": false }, "created": "2017-12-08T14:51:32.000701+00:00", "custom_fields": {}, "deletion_status": { "is_deleted": false, "status": "P" }, "id": "c34f37d2-1130-4b20-9184-363e7398d0b4", "links": {}, "metadata": { "curation_policy": "Open Notebooks
\r\n", "description": "Open Notebooks", "page": "Open Notebooks
\r\n", "title": "Open Notebooks" }, "revision_id": 0, "slug": "openlabnotebooks", "updated": "2017-12-08T14:51:32.000708+00:00" }, { "access": { "member_policy": "open", "members_visibility": "public", "record_policy": "open", "review_policy": "open", "visibility": "public" }, "children": { "allow": false }, "created": "2021-03-13T19:45:11.575007+00:00", "custom_fields": {}, "deletion_status": { "is_deleted": false, "status": "P" }, "id": "dc7d9bf2-d761-453f-9ae6-9f14a5a5e209", "links": {}, "metadata": { "curation_policy": "YCharOS's team is entitled to upload antibody characterization studies.
\r\n", "page": "YCharOS' mission is to conduct antibody characterization studies for every human protein. Antibody characterization reports are being uploaded in this community.
\r\n\r\nYCharOS follows an antibody characterization pipeline published in 2019 in eLife: https://elifesciences.org/articles/48363
\r\n\r\nFor more information, please visit our webpage:
\r\n\r\nhttps://ycharos.com/
", "title": "YCharOS - Antibody Characterization Through Open Science" }, "revision_id": 0, "slug": "ycharos", "updated": "2021-04-28T00:57:37.761483+00:00" } ], "ids": [ "202e8f59-215b-490f-a257-f0273d2ec041", "23286851-d31a-4dfe-9957-6de5a081d5bb", "c34f37d2-1130-4b20-9184-363e7398d0b4", "dc7d9bf2-d761-453f-9ae6-9f14a5a5e209" ] }, "id": "4627529", "pids": { "doi": { "client": "datacite", "identifier": "10.5281/zenodo.4627529", "provider": "datacite" } } }, "pids": { "doi": { "client": "datacite", "identifier": "10.5281/zenodo.4627530", "provider": "datacite" }, "oai": { "identifier": "oai:zenodo.org:4627530", "provider": "oai" } }, "revision_id": 7, "stats": { "all_versions": { "data_volume": 499000068.0, "downloads": 315, "unique_downloads": 294, "unique_views": 426, "views": 453 }, "this_version": { "data_volume": 299634552.0, "downloads": 189, "unique_downloads": 175, "unique_views": 254, "views": 270 } }, "status": "published", "updated": "2022-09-29T14:57:43.895802+00:00", "versions": { "index": 1, "is_latest": false } }